Mary Lynne Hedley, Ph.D. has been appointed executive vice president of operations and chief scientific officer of Abraxis BioScience. Dr. Hedley most recently served as executive vice president of Eisai Corp. of North America following Eisai’s acquisition of MGI Pharma, where she had served as executive vice president and chief scientific officer since 2005. She joined MGI in 2004 as senior vice president and general manager. Previously, Dr. Hedley co-founded Zycos, Inc., a biotechnology compan...